ConductScience.org, home

Paper5125

Spectroscopic studies on the complex formation of suramin with bovine and human serum albumin.

Müller WE and 1 other. Biochim Biophys Acta, 1976. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Spectroscopic studies on the complex formation of suramin with bovine and human serum albumin. Papers, record 5125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5125

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spectroscopic studies on the complex formation of suramin with bovine and human serum albumin.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2019-06-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Müller WEW E
2Wollert UU

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Serum AlbuminMajor topic
Serum Albumin, BovineMajor topic
SuraminMajor topic
Anilino Naphthalenesulfonates
Binding Sites
Circular Dichroism
Humans
Hydrogen-Ion Concentration
Kinetics
Protein Binding
Protein Conformation
Species Specificity
Spectrometry, Fluorescence
Spectrophotometry
Spectrophotometry, Ultraviolet

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
16158305The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.Naunyn Schmiedebergs Arch Pharmacol2005https://conductscience.org/library/papers/16158305PubMed
2457568On the alcianophilia of the drug suramin used as a tool for inducing experimental mucopolysaccharidosis.Histochemistry1988https://conductscience.org/library/papers/2457568PubMed
1810199The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1810199PubMed
1731751Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.Biochem J1992https://conductscience.org/library/papers/1731751PubMed
568220Induction of lysosomal storage by suramin.Naunyn Schmiedebergs Arch Pharmacol1978https://conductscience.org/library/papers/568220PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5125

GET https://conductscience.org/api/papers/v1/5125/authors